Streetbeat News

Products Services

BRPHF

BTCUSD

Mike Novogratz, CEO of Galaxy Digital, expressed optimism about future positive cryptocurrency legislation in the U.S., regardless of the election outcome. He emphasized the need for bipartisan support and noted a shift in attitudes towards crypto regulation. Novogratz also discussed Bitcoin's market position and the impact of government spending on its relevance.

Portfolio Pulse from Murtuza Merchant

July 03, 2024 | 3:36 pm

GOEV

Canoo (NASDAQ:GOEV) shares are trending after announcing a purchase agreement with Go2 Delivery, receiving multiple design awards, and joining the Russell 3000 index. Despite these positive developments, the stock is trading 3.04% lower at $2.25.

Portfolio Pulse from Dylan Berman

July 03, 2024 | 3:35 pm

LLY

NVO

Novo Nordisk and Eli Lilly shares are trading lower due to a report suggesting a link between Ozempic and a higher risk of a serious eye condition.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 3:34 pm

SFL

SFL Corp has announced a newbuild order for five LNG dual-fuel 16,800 TEU container vessels, combined with long-term charters. The vessels are scheduled for delivery in 2028, with a construction cost of approximately $1 billion.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 3:34 pm

FXI

TSLA

VGK

Tesla received EU inspectors at its Chinese factories last week. This inspection could result in Tesla getting a lower duty than the average 21% imposed on Chinese EV-makers.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 3:32 pm

LLY

NVO

A new observational study has linked Novo Nordisk's GLP-1 drugs Ozempic and Wegovy to a higher risk of nonarteritic anterior ischemic optic neuropathy (NAION), an eye condition that can cause vision loss. The study found a significantly higher incidence of NAION in patients prescribed semaglutide compared to those on non-GLP-1 drugs. Novo Nordisk has responded by emphasizing the safety profile of semaglutide, though the study's authors call for further research.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 3:31 pm

ASML

ASML Holding N.V. (NASDAQ:ASML) shares are trading higher following a court ruling that allows the company to proceed with its expansion plans at its headquarters in Veldhoven, Netherlands. The court dismissed objections from neighbors regarding traffic and noise concerns, supporting the approval granted by Veldhoven’s town council in 2022. The expansion aims to support ASML’s growth and includes a larger project in Eindhoven to accommodate 20,000 new employees by 2030.

Portfolio Pulse from Shivani Kumaresan

July 03, 2024 | 3:13 pm

LLY

NVO

A new study from Massachusetts Eye and Ear has found a potential link between semaglutide, the active ingredient in Ozempic and Wegovy, and a serious eye condition called nonarteritic anterior ischemic optic neuropathy (NAION). The study indicates that diabetics on semaglutide have a four times higher risk of developing NAION, while those taking the drug for weight loss have a seven times higher risk. The findings were published in JAMA Ophthalmology.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 3:03 pm

BABA

FUTU

FXI

KWEB

Futu Holdings Limited (NASDAQ:FUTU) stock is trading higher due to a tech rally led by Alibaba Group Holding Limited (NYSE:BABA) in Hong Kong. Futu also announced its wealth management business has surpassed $10 billion in assets under management. Investors can gain exposure to the Chinese equity market via iShares China Large-Cap ETF (NYSE:FXI) and KraneShares CSI China Internet ETF (NYSE:KWEB).

Portfolio Pulse from Anusuya Lahiri

July 03, 2024 | 2:55 pm

DECA

SCLX

Semnur Pharmaceuticals, a subsidiary of Scilex Holding Company (NASDAQ:SCLX), has signed a $2 billion SPAC deal with Denali Capital Acquisition Corp. (NASDAQ:DECA) to go public. Semnur focuses on non-opioid pain therapies and has a promising lead program, SP-102 (SEMDEXA), which has shown positive Phase 3 trial results for treating sciatica. The deal is expected to be completed in the second half of 2024, with potential peak sales of $3.6 billion annually.

Portfolio Pulse from Vandana Singh

July 03, 2024 | 2:51 pm